eyestock logo

eyestock

Markets
Catalog
Exchange: XLON
Sector: Healthсare
Ticker: STX.L

ST

Shield Therapeutics PLCLSE Shield Therapeutics Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

—

Market cap $B

0.044

Micro

Exchange

XLON - London Stock Exchange

View Full Company Analysis

Return on assets ROA

-76 %

Last period ROA

-70%

ROA has decreased in 5 years

‌

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

See also Shield Therapeutics

Company Analysis

STX.L valuation, rating, competitors, insights and company profile

Eyestock Rating

STX.L financial analysis by Eyestock methodology

Valuation

STX.L valuation using historical relative method

Statements

STX.L Income Statements, Balance Sheet and Cash Flow Statements

Dividends

STX.L dividend yield and annual dividend

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

What is ROA of Shield Therapeutics ?

Shield Therapeutics`s ROA for the last twelve months ended 2024-06-30 is -76 %

View Full Company Analysis
Watchlist

Discover

Stock AnalysisScreenerPortfolio